The study has been carried out to highlight the potential of thiosemicarbazones in crystal engineering.
This study introduces novel coumarin–hydrazone hybrids, assessed for their potential as α-glucosidase inhibitors to treat diabetes. Compounds checked for α-glucosidase inhibition and